Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move more”—rarely works because everyone’s body is different. That’s where personalized ...

Adding human coaches to artificial intelligence-powered weight-loss programs significantly boosts user success, underscoring ...

Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New ...

GLP-1 weight loss medications: Providers can prescribe brand-name GLP-1 agonist medications, including Wegovy and Zepbound, ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

Adding human coaches to artificial intelligence-powered weight-loss programs significantly boosts user success, underscoring the value of hybrid human-AI models in digital health, a new study suggests ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published, examining their ability to reduce weight and waist circumference. And one ...

Get the skinny on getting skinny. — -- Just in time for swimsuit season, a new study has come out saying there's very little scientific evidence to prove most diet and weight-loss regimens ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

GLP-1 medications can come with a steep price tag, and although discounted options are now available, doctors have some concerns.

Non-profit Gates Foundation and UN specialized health agency Pan American Health Organization (PAHO) are both mulling ...

States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by ...